Mark N. Cruickshank
-
- Birth, Development, and Health 4
-
- Epigenetics and DNA Methylation 7
- Protein Degradation and Inhibitors 3
- Cancer-related gene regulation 3
-
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 5
-
- CAR-T cell therapy research 3
- Co-authors
- Jeffrey M. CraigRichard SafferyLavinia GordonMiina OllikainenDavid MartinoDaniela UlgiatiYuk Jing LokeLawrence J. Abraham
- Journals
- Oncogene (1 paper)Biochemical and Biophysical Research Communications (1 paper)Genome Research (1 paper)
- Partner nations
- AustraliaUnited StatesFinland
In The Last Decade
Mark N. Cruickshank
24 papers receiving 708 citations
Peers
Comparison fields: 5 of 97
- Pediatrics, Perinatology and Child Health 184
- Molecular Biology 460
- Genetics 162
- Immunology 111
- Obstetrics and Gynecology 36
Countries citing papers authored by Mark N. Cruickshank
This map shows the geographic impact of Mark N. Cruickshank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Cruickshank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Cruickshank more than expected).
Fields of papers citing papers by Mark N. Cruickshank
This network shows the impact of papers produced by Mark N. Cruickshank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Cruickshank. The network helps show where Mark N. Cruickshank may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark N. Cruickshank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 18 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 9 | |
| 6 | 2019 | 10 | |
| 7 | 2019 | 6 | |
| 8 | 2018 | 67 | |
| 9 | 2016 | 18 | |
| 10 | 2015 | 3 | |
| 11 | 2015 | 1 | |
| 12 | 2013 | 83 | |
| 13 | 2012 | 12 | |
| 14 | 2012 | 180 | |
| 15 | 2012 | 16 | |
| 16 | 2010 | 22 | |
| 17 | 2009 | 7 | |
| 18 | 2009 | 48 | |
| 19 | 2009 | 19 | |
| 20 | 2007 | 17 |
About Mark N. Cruickshank
Mark N. Cruickshank is a scholar working on Immunology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 24 papers that have together received 722 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers), Birth, Development, and Health (4 papers), CAR-T cell therapy research (3 papers), Protein Degradation and Inhibitors (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (184 citations), Molecular Biology (460 citations) and Genetics (162 citations). Mark N. Cruickshank has collaborated with scholars based in Australia, United States and Finland. Frequent co-authors include Jeffrey M. Craig, Richard Saffery, Lavinia Gordon, Miina Ollikainen, David Martino, Daniela Ulgiati, Yuk Jing Loke, Lawrence J. Abraham, Jihoon E. Joo and Boris Novakovic. Their work appears in journals such as Oncogene, Biochemical and Biophysical Research Communications and Genome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.